These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7267033)

  • 21. On the pathogenesis of diabetic retinopathy.
    Frank RN
    Ophthalmology; 1984 Jun; 91(6):626-34. PubMed ID: 6205341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between human growth hormone (HGH) concentration in blood plasma and the evolution of diabetic retinopathy.
    Sévin R
    Ophthalmologica; 1972; 165(1):71-7. PubMed ID: 5069892
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemorheological alterations in patients with diabetic retinopathy.
    Vekasi J; Marton ZS; Kesmarky G; Cser A; Russai R; Horvath B
    Clin Hemorheol Microcirc; 2001; 24(1):59-64. PubMed ID: 11345235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of serotonin in the pathogenesis of diabetic retinopathy and central chorioretinal dystrophy].
    Mukha AI; Korzenkova LV; Fedorova NV; Syromiatnikova ED
    Vestn Oftalmol; 2002; 118(4):31-3. PubMed ID: 12371320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of abnormal hemorrheodynamics in the pathogenesis of diabetic retinopathy.
    Little HL
    Trans Am Ophthalmol Soc; 1976; 74():573-636. PubMed ID: 867639
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
    Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
    Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traditional and novel risk factors of diabetic retinopathy and research challenges.
    Tan GS; Ikram MK; Wong TY
    Curr Med Chem; 2013; 20(26):3189-99. PubMed ID: 23745545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the growth hormone secretion in diabetic retinopathy. 3. Alteration of serum insulin secretion in relation to diabetic retinopathy and growth hormone].
    Takeo K
    Nippon Ganka Gakkai Zasshi; 1971 Jan; 75():543-54. PubMed ID: 5103207
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of platelets in diabetic microangiopathy--an additional factor.
    Chitre AP; Velaskar DS
    Angiology; 1988 May; 39(5):458-65. PubMed ID: 3377267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation and retinal microangiopathy in diabetes and hypertension.
    Khosla PK; Mahabaleswara M; Tiwari HK; Saraya AK
    Acta Haematol; 1979; 61(3):161-7. PubMed ID: 108893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats.
    Ishibashi T; Tanaka K; Taniguchi Y
    Diabetes; 1981 Jul; 30(7):601-6. PubMed ID: 7250530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy.
    Hanssen KF
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):64-74. PubMed ID: 4406482
    [No Abstract]   [Full Text] [Related]  

  • 33. Aggregate formation of erythrocytes and diabetic retinopathy in children, adolescents, and adults with diabetes mellitus (type I).
    Tillmann W; Lakomek M; Heidemann P; Behrens-Baumann W; Schröter W
    Klin Wochenschr; 1984 Dec; 62(23):1136-9. PubMed ID: 6521362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of diabetic retinopathy--observations on thrombus formation in vitro].
    Zhu ZR
    Zhonghua Yi Xue Za Zhi; 1983 Apr; 63(4):219-22. PubMed ID: 6413018
    [No Abstract]   [Full Text] [Related]  

  • 35. [Red blood cell aggregability in diabetic retinopathy].
    Miyashita K; Tanahashi N; Akiya S
    Nippon Ganka Gakkai Zasshi; 1988 Jul; 92(7):1166-70. PubMed ID: 3189092
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus.
    Kirkegaard C; Nørgaard K; Snorgaard O; Bek T; Larsen M; Lund-Andersen H
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):766-72. PubMed ID: 2197845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Course of diabetic retinopathy and metabolic control with subcutaneous insulin infusion pump: 18-month study].
    Goicolea I; Santamaría E; Pardo C; Vázquez JA; Martín A; Castresana I
    An Med Interna; 1989 Feb; 6(2):71-3. PubMed ID: 2491075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide-cGMP and prostacyclin-cAMP pathways in patients with type II diabetes and different types of retinopathy.
    De La Cruz JP; Moreno A; Guerrero A; Ortega G; González-Correa JA; Sánchez de la Cuesta F
    Pathophysiol Haemost Thromb; 2002; 32(1):25-32. PubMed ID: 12214160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deranged Metabolic Profile and Identification of Biomarkers in the Vitreous Humour of Patients with Proliferative Diabetic Retinopathy.
    Sahajpal NS; Vig VK; Singh R; Singh H; Chaubey A; Singh K; Goel RK; Jain SK
    Protein Pept Lett; 2018; 25(8):791-798. PubMed ID: 30129402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.